TheChek News Flow

>>> Up

* Aker BP Raised to Buy at SEB Equities; PT 260 kroner

* Antin Raised to Buy at Citi; PT 14.90 euros

* AT&T Raised to Outperform at RBC; PT $26

* Barratt Redrow PLC Raised to Buy at Redburn; PT 540 pence

* Boeing Raised to Overweight at Barclays

* Booz Allen Raised to Equal-Weight at Barclays

* CVC Capital Raised to Buy at Citi; PT 25.30 euros

* Diversified Energy PT Raised to $27 from $21 at Truist Secs

* EnQuest Raised to Buy at Jefferies; PT 15 pence

* European Medtech Sector Upgraded at Morgan Stanley, Qiagen Cut

* Experian Raised to Outperform at RBC; PT 4,200 pence

* Hermes Raised to Buy at Stifel; PT 2,560 euros

* IPC Raised to Buy at Jefferies; PT 140 kronor

* Medacta Raised to Overweight at Morgan Stanley

* Persimmon Raised to Buy at Redburn; PT 1,510 pence

* Siemens PT Raised to 245 euros from 215 euros at Berenberg

* Spectris Raised to Buy at HSBC; PT 2,900 pence

* Tesla Raised to Hold at Punto Casa de Bolsa; PT $364.44

>>> Down

* Berkeley Cut to Neutral at Redburn; PT 4,460 pence

* Crest Nicholson Cut to Neutral at Redburn; PT 186 pence

* Energean Cut to Underperform at Jefferies; PT 800 pence
* Equinor Cut to Neutral at SpareBank; PT 290 kroner

* Ocado PT Cut to 230 pence from 235 pence at Morgan Stanley

* Rolls-Royce Cut to Neutral at Citi; PT 641 pence

* Royal Unibrew Cut to Equal-Weight at Barclays; PT 653 kroner

* T-Mobile Cut to Sector Perform at RBC; PT $240

* Unilever Cut to Underperform at RBC; PT 4,000 pence

>>> Initiation

* Bytes Technology Rated New Buy at Investec; PT 600 pence

* Hilton Grand Vacations Rated New Overweight at Morgan Stanley

* Marriott Vacations Rated New Underweight at Morgan Stanley
* Palantir Assumed Underweight at Morgan Stanley; PT $60

* Travel + Leisure Co Rated New Overweight at Morgan Stanley

>>> Call

* European Medtech Sector Upgraded at Morgan Stanley, Qiagen Cut

* Ned Davis Warns It May Cut Exposure to US Equities After Selloff
* Rolls-Royce Shares Downgraded to Neutral at Citi on Valuation

* Unilever’s Outperformance Seems Excessive, RBC Downgrades